Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN107698648B reveals a novel synthesis for cholesterol-naphthalimide hybrids with anticancer and liquid crystal applications, offering scalable routes for high-purity intermediates.
Novel CDI-catalyzed method ensures high purity nitazoxanide. Reduces impurities significantly for reliable pharmaceutical intermediate supply chain.
Advanced patent-based method for solifenacin intermediate production offering high purity and reduced waste for global pharmaceutical supply chains.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Novel 3-step synthesis of 2-amino-5-bromo-3-hydroxypyridine via photocatalysis. Cost-effective, scalable API intermediate manufacturing.
Novel synthesis method for L-6-hydroxytryptophan derivatives offers high yield and scalable production for pharmaceutical intermediates and polypeptide drug development.
Patent CN105001159A enables chiral phosphoric acid catalysis for quinoline-3-amine hydrogenation. Delivers high ee values and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN115124470B details improved synthesis for cancer treatment intermediates. Enhances supply chain reliability and reduces manufacturing costs through scalable chemistry.
Patent CN115108979B reveals a mild synthesis route for 8-hydroxyquinoline derivatives, offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN103980152B reveals novel benzamide synthesis. Offers cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Novel method for Lidocaine Hydrochloride Impurity E ensuring high purity and yield for pharmaceutical quality control and supply chain stability.
Patent CN105801336A reveals high-yield phenanthrene synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN103360217B details high-purity chiral reagent synthesis. Reduces time and cost for biotin intermediate production significantly.
Patent CN102336642B reveals a scalable chemical route for immunosuppressive polyketides, offering reliable supply and cost advantages over fermentation for pharmaceutical manufacturers.
Patent CN109666030B details a novel spirocyclic amine catalyzed route for codeine and morphine, offering high enantioselectivity and supply chain independence from poppy cultivation.
Patent CN117534554B reveals a novel synthetic route for deoxyshikonin. This method offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110862325B reveals a novel asymmetric cycloaddition route for high-purity Bictegravir intermediates, offering significant cost reduction and supply chain reliability.
Patent CN110777391B reveals a green electroreduction method for gefitinib intermediates, offering high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN107382884A reveals a metal-free synthesis route for beta-iodo-N-alkoxy benzotriazoles, offering safer conditions and cost reduction in pharmaceutical intermediate manufacturing.